Valeo Pharma Inc VPHIF

Healthcare

Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler, Atectura Breezhaler and Allerject. The ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis and Ametop Gel 4%. The Company's wholly owned subsidiary is VPI Pharmaceuticals Inc.

GREY:VPHIF - Post by User

Valeo Pharma Inc > Hesperco get the green light with Health Canada

<< Previous

Bullboard Posts

Next >>

Comment by eric40on Sep 08, 2020 7:04pm

150 Views

Post# 31524506

RE:RE:Hesperco get the green light with Health Canada

You are right, this is a natural product. It cannot be patent protected. However, it is just a matter of good marketing and taking advantage of the covid situation with a brand name for a product that help boost the immune system. So why not. Hesperco won't bring sales of 100 millions (well we never know with the covid situation!) but it will probably bring a nice add up revenu and and is low cost high margin.

The approval of Redeska is what I am waiting for. It should come anytime now and this will bring huge revenu.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario